BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 7049191)

  • 1. Intraperitoneal insulin: new alternative for diabetic CAPD patients.
    Bandel-Walcer R; Myers C; Malgaonkar S; Lyman N
    AANNT J; 1982 Aug; 9(4):31-5. PubMed ID: 7049191
    [No Abstract]   [Full Text] [Related]  

  • 2. Intraperitoneal insulin for control of glucose level in insulin dependent diabetic patients treated by CAPD.
    Rottembourg J; Balducci A; Baumelou A; Jacq D; Agrafiotis A; Slama G
    Proc Clin Dial Transplant Forum; 1980; 10():305-7. PubMed ID: 7050993
    [No Abstract]   [Full Text] [Related]  

  • 3. Continuous ambulatory peritoneal dialysis in diabetes mellitus. The risks and benefits of intraperitoneal insulin.
    Madden MA; Zimmerman SW; Simpson DP
    Am J Nephrol; 1982; 2(3):133-9. PubMed ID: 6758585
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Peritoneal dialysis for diabetic nephropathy: a case of intraperitoneal insulin administration].
    Abe T; Kusumi H; Kanazawa M
    Hinyokika Kiyo; 1972 Mar; 18(3):133-6. PubMed ID: 5065298
    [No Abstract]   [Full Text] [Related]  

  • 5. [Continuous ambulatory peritoneal dialysis treatment and blood glucose control in diabetics with end-stage diabetic nephropathy].
    Li GW; Liu J; Chen L
    Zhonghua Nei Ke Za Zhi; 1989 Jun; 28(6):360-3, 382. PubMed ID: 2684575
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Xylitol as osmotic agent in CAPD: an alternative to glucose for uremic diabetic patients?
    Bazzato G; Coli U; Landini S; Fracasso A; Morachiello P; Righetto F; Scanferla F; Onesti G
    Trans Am Soc Artif Intern Organs; 1982; 28():280-6. PubMed ID: 6761936
    [No Abstract]   [Full Text] [Related]  

  • 7. Peritoneal dialysis in diabetics. Optimal insulin therapy on CAPD: intraperitoneal versus subcutaneous treatment.
    Scarpioni L; Ballocchi S; Scarpioni R; Cristinelli L
    Perit Dial Int; 1996; 16 Suppl 1():S275-8. PubMed ID: 8728206
    [No Abstract]   [Full Text] [Related]  

  • 8. Intraperitoneal insulin in the diabetic continuous ambulatory peritoneal dialysis (CAPD) patient - nursing management.
    Adair CM
    AANNT J; 1982 Apr; 9(2):62-3. PubMed ID: 7039632
    [No Abstract]   [Full Text] [Related]  

  • 9. Visual function, blood pressure and blood glucose in diabetic patients undergoing continuous ambulatory peritoneal dialysis.
    Rottembourg J; Bellio P; Maiga K; Remaoun M; Rousselie F; Legrain M
    Proc Eur Dial Transplant Assoc Eur Ren Assoc; 1985; 21():330-4. PubMed ID: 3991520
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Intraperitoneal insulin in continuous ambulatory peritoneal dialysis].
    Riambau E; Aubia J; Llorach I; Lloveras J; Masramón J; Orfila A; Llorach M
    Rev Clin Esp; 1982 Mar; 164(5):333-4. PubMed ID: 7048442
    [No Abstract]   [Full Text] [Related]  

  • 11. Intraperitoneal insulin in diabetic CAPD patients.
    Mactier RA; Khanna R
    Int J Artif Organs; 1988 Jan; 11(1):9-12. PubMed ID: 3283057
    [No Abstract]   [Full Text] [Related]  

  • 12. [Management of blood glucose in diabetic dialysis patients].
    Hori K; Fujimi S
    Nihon Rinsho; 1992 Jan; 50 Suppl():192-6. PubMed ID: 1578677
    [No Abstract]   [Full Text] [Related]  

  • 13. Three diabetic peritoneal dialysis patients receiving intraperitoneal insulin with dosage adjustment based on capillary glucose levels during peritoneal equilibrium tests.
    Thorp ML; Wilks TS
    Am J Kidney Dis; 2004 May; 43(5):927-9. PubMed ID: 15112185
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The influence of peritoneal dialysis and the use of subcutaneous and intraperitoneal insulin on glucose metabolism and serum lipids in type 1 diabetic patients.
    Nevalainen P; Lahtela JT; Mustonen J; Pasternack A
    Nephrol Dial Transplant; 1997 Jan; 12(1):145-50. PubMed ID: 9027790
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Efficacy of the administration of intraperitoneal insulin in diabetic patients undergoing continuous ambulatory peritoneal dialysis].
    Coronel Díaz F; Naranjo Gómez P; Serrano Heranz R; Cruceyra Ventín A; Prats Sánchez D
    Med Clin (Barc); 1984 May; 82(20):881-4. PubMed ID: 6379332
    [No Abstract]   [Full Text] [Related]  

  • 16. Insulin therapy during peritoneal dialysis: pros and cons of various forms of administration.
    Quellhorst E
    J Am Soc Nephrol; 2002 Jan; 13 Suppl 1():S92-6. PubMed ID: 11792768
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intraperitoneal insulin in continuous ambulatory peritoneal dialysis (CAPD): clinical aspects.
    Triolo G; Carta Q; Salomone M; Dani F; Passarino G; Boggio Bertinet D; Segoloni GP; Vercellone A
    Life Support Syst; 1983; 1 Suppl 1():454-6. PubMed ID: 6400733
    [No Abstract]   [Full Text] [Related]  

  • 18. Continuous ambulatory peritoneal dialysis in the treatment of end-stage diabetic nephropathy.
    Grefberg N; Danielson BG; Nilsson P
    Acta Med Scand; 1984; 215(5):427-34. PubMed ID: 6377827
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Decreasing insulin requirements in CAPD patients given intraperitoneal insulin.
    Grefberg N; Danielson BG; Berne C
    J Diabet Complications; 1987; 1(1):16-9. PubMed ID: 2968990
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Continuous ambulatory peritoneal dialysis in diabetics with end-stage renal disease.
    Amair P; Khanna R; Leibel B; Pierratos A; Vas S; Meema E; Blair G; Chisolm L; Vas M; Zingg W; Digenis G; Oreopoulos D
    N Engl J Med; 1982 Mar; 306(11):625-30. PubMed ID: 7035945
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.